The 3rd Meeting of ACTO

Dear Colleagues,

On behalf of the Asian Cellular Therapy Organization and the Thai Society of Hematology, we have a great pleasure to invite you to attend the 3rd Meeting of Asian Cellular Therapy Organization (ACTO 2012) which will be held at the Le Méridien, Chiangmai, Thailand during November 15-17, 2012. This meeting is intended to present the most up-to-date scientific discussion of the development of equipment and treatments in the field of cellular therapy on hematopoietic stem cell transplant, immunotherapy, regenerative medicine, gene therapy and regulatory issue. The scientific session will give all participants a chance to share the latest knowledge and experience.

Please be announced that early registration and abstract submission for the ACTO 2012 is now open. We also would like to invite you to present your research work as the oral or poster presentation in the meeting.

The deadline for early registration and abstract submission is September 30, 2012. For further information, please visit our website at http://www.acto2012.org .

If you have any questions or need assistance, please contact the secretariat by email. We look forward to your participation in ACTO 2012 in this coming November.

Yours sincerely,

Secretariat of ACTO 2012
c/o The Thai Society of Hematology
10th Floor, the Royal Golden Jubilee Bldg.
2 SoiSoonvijai, New Petchburi Road
Bangkok 10210
Phone: +662 716-5977
Fax: +662 716-5978
Email: secretariat@acto2012.org
      Joi_kt@hotmail.com

Invitation Letter to the 3rd Meeting of ACTO

Dear ISCT Asia members

It is our pleasure to announce that ISCT Asian Regional Meeting changed to a new academic society named ACTO (Asian Cellular Therapy Organization).

ISCT Asia was one of to branch societies of ISCT (International Society for Cellular Therapy) as ISCT-Europe and ISCT-Australia/New-Zealand. From last year, these regional operations have appealed that the autonomous regional activity independent of ISCT HQ was important for region-oriented development of cellular therapy.

On May 2011, our Asian group decided to establish a new group for progress of cellular therapy more based on Asian situation. Along with the independence from ISCT, the name was changed to ACTO by many members’ suggestions.

Even though the name was changed, the aim and activity of our society continue without change. The 2nd Meeting will also be held on October 17-20, 2011 at Miyazaki, like as last year, named as “The 2nd Meeting of ACTO”.

It would be greatly appreciated if you worked together for the new Asian Cellular Therapy Organization.

Sincerely,
Akihiro Shimosaka, Ph. D,
Chairperson, ACTO

Senior Research Adviser
Division of Stem Cell Therapy
Center for Stem Cell Biology and Regenerative Medicine
The Institute of Medical Science,
The University of Tokyo

Director
Research and Development Division
Research Foundation for Community Medicine

P.S.

This year, the 3rd meeting of ACTO will be held in Chiang Mai,
Thailand on Nov.16 and 17, 2012. We will give you further
information about it as soon as possible.

To Committee members and Region Members

To Committee members of ISCTasia Regional Operation and ISCTasia Region Members

Dear Friends :

I would like to express our sincere gratitude to your suppport and encouragement for Japanese who are now facing the disaster caused by M 9.0 earthquake, tsunami and ongoing accident at nuclear power plants in Fukushima.

As you may remember, we organized the first Asian regional Meeting for ISCT at Miyazaki last year. We are planning to have the second ISCTasia meeting in coming October at the same city. However, considering the last disaster, we will make a final desicion whether we will be able to host the meeting at the beginning of May. Please wait for another month to obtain the final draft for the second ISCTasia meeting.

We just opened ISCTasia office at National Cancer Center in Tokyo where Dr. Yuji Heike and Takako Wakeda are supporting the ISCTasia regional operation. This office will help all of you communicate with each other and exchange the information to activate the research and development of cellular therapy in Asia. Please feel free to contact the ISCTasia office at any time through our website.

Thank you again for your support and we are looking forward to working together with you.

Sincerely,
Akihiko Shimosaka PhD
Vice President, ISCTasia